Eosinophilic Asthma Latest Advances
Find the Latest Research About Eosinophilic Asthma
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1822 publications
Residual exacerbation phenotypes during anti-IL-5/IL-5R (IL-5 receptor) therapy in severe eosinophilic asthma.
Journal: Allergy and asthma proceedings
Published: October 29, 2026
Positioning of Depemokimab in Uncontrolled Severe Asthma.
Journal: Journal of investigational allergology & clinical immunology
Published: October 19, 2026
Gut-Mitophagy-Ferroptosis Axis in Asthma: Microvirga-TP53-PARP11 Crosstalk as a Quantifiable Target for Childhood Asthma Prevention.
Journal: Critical reviews in eukaryotic gene expression
Published: October 13, 2026
Individualising biologic therapy for paediatric severe asthma: A comparative review of all five approved agents, real-world evidence, and a biomarker-guided clinical decision algorithm.
Journal: Therapeutic advances in respiratory disease
Published: October 10, 2026
Nocardia lung infection in severe asthma with immune dysfunction.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: September 15, 2026
Identification of severe eosinophilic asthma in patients with chronic rhinosinusitis and nasal polyps who are awaiting sinus surgery.
Journal: The journal of allergy and clinical immunology. Global
Published: September 14, 2026
Phenotypic predictors of response to IL-5 pathway inhibitors in severe eosinophilic asthma: a retrospective real-world cohort.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: September 11, 2026
Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia.
Journal: Therapeutic advances in respiratory disease
Published: August 28, 2026
Skin Deep: A Case Report of Erythema Nodosum Induced by Dupilumab Therapy.
Journal: Cureus
Published: August 28, 2026
Small airway dysfunction and associated clinical characteristics in severe asthma under omalizumab and mepolizumab treatment.
Journal: Asian Pacific journal of allergy and immunology
Published: August 23, 2026
Three-year sustained remission with mepolizumab in a rare eosinophilic disease: idiopathic chronic eosinophilic pneumonia.
Journal: European clinical respiratory journal
Published: August 13, 2026
Last Updated: 11/08/2026